Mikhail Blagosklonny is an expert Oncologist medical doctor and scientist who has pioneered advancement in cancer treatment therapy and anti-aging. Mikhail instructs students at Roswell Park Cancer Institute as a professor of oncology. He is renown among his constituents for breakthrough contributions for his cutting-edge work with experimental medicine in both cancer treatment and youth restoration. Blagosklonny’s work has led to the discovery of the drug rapamycin which can be used to treat cancer. Rapamycin’s clinical study showed it can suppress cancer cells and encourage life extension.
He has done extensive research in the medical fields of cancer, cell cyclotherapy, chemotherapeutic engineering, biogerontology and molecular biology. Mikhail has authored an extensive number (over 300) of scientific and medical publications related to the causes and treatment of cancer and aging. He is one of the editor-in-chiefs of Oncotarget. Oncotarget is a peer-reviewed medical journal that is released weekly and reports findings on various facets of tumor treatment and oncology matters. Three of his other ongoing publications are Oncoscience, Aging and Cell Cycle. He is also known for his associate editorial contributions to Cancer Biology, Therapy, Autophagy, Cancer Research, International journal of Medicine, Plos One, The American Journal of Pathology and as an associate of the editorial board of Cell Death and Differentiation. Visit ResearchGate to keep up to date with Mikhail’s latest work.
Blagosklonny attained his PhD in experimental medicine and M.D. in internal medicine at First Pavlov State Medical University in St. Petersburg, Russia. He has had a notable career as a professor at New York Medical College in Valhalla, New York and as an oncology professor at the Roswell Park Cancer Institute in Buffalo, New York. His scientific forte and interests include drug resistance for selective protection of normal cells, apoptosis, signal transduction, mitosis and developing innovative strategies for cancer treatment. Mikhail Blagosklonny is an expert and author of aging hyper function theory. This theory asserts that hyper function or excessive cellular activity is one of the leading traits of aging. Pro-aging signal transduction pathways and possible anti-aging properties that bombard them are now available to counter the aging process. Blagosklonny suggests that rapamycin and metformin are two such countering agents.
Mikhail’s commitment and comprehensive research studies has afforded him in being recognized as one of the most top leaders in the field of oncology. His compassion for people and eliminating pain and suffering from cancer is one of the driving factors that keep him forging ahead in the quest for becoming disease free. Mikhail Blagosklonny has a genius acumen and an unwavering fortitude in discovering breakthrough in anti-aging and a cure for cancer! He has arguably been one of the biggest contributors worldwide in understanding what causes aging and cancer and what can be used to eliminate it. It is caused by overstimulated cellular activity. He has shown verifiable evidence that aging is not caused by the accumulation of molecular damage. Perhaps, through the administering use of rapamycin we not only have the fountain of youth but the ability to wipe out cancer once and for all.